News & Updates

Nomogram identifies burned children at risk of infections

03 Dec 2024 by

A newly developed nomogram demonstrates its ability to predict the risk of healthcare-associated infections (HAIs) in burned children. This prediction model is based on factors such as larger burns, longer length of stay (LOS), and use of central venous catheter (CVC), among others.

Nomogram identifies burned children at risk of infections

03 Dec 2024

Why not metformin for long COVID in non-diabetics?

03 Dec 2024 by

Metformin prescribed within a week of SARS-CoV-2 infection was associated with a 53-percent reduction in long COVID or death over 6 months in patients without diabetes or prediabetes, as shown in a simulation study presented at IDWeek 2024.

Why not metformin for long COVID in non-diabetics?

03 Dec 2024

Wearable TENS device may zap away pain, fatigue due to long COVID

02 Dec 2024 by

Daily transcutaneous electrical nerve stimulation (TENS) therapy using a wearable device holds promise in alleviating pain, fatigue, and gait alterations in individuals with long COVID, as shown in a pilot study.

Wearable TENS device may zap away pain, fatigue due to long COVID

02 Dec 2024

7 days of antibiotics as effective as 14 days for bloodstream infections

02 Dec 2024 by

In the noninferiority BALANCE* trial, 7 days of antibiotic use is as effective as 14 days for treating bloodstream infections (BSIs) in hospitalized patients, drawing renewed interest from clinicians attending IDWeek 2024.

7 days of antibiotics as effective as 14 days for bloodstream infections

02 Dec 2024

Meropenem-vaborbactam on par with ceftazidime-avibactam for survival in CRE infections, with an edge against resistance emergence

30 Nov 2024 by

The likelihood of survival at 30 days among patients with CRE infections is similar for those who receive ceftazidime-avibactam or meropenem-vaborbactam. However, recurrent infections and the emergence of resistance are observed less frequently with the latter carbapenem/BLI combination, as suggested by a prospective observational study presented at IDWeek 2024

Meropenem-vaborbactam on par with ceftazidime-avibactam for survival in CRE infections, with an edge against resistance emergence

30 Nov 2024

Widespread “test-and-treat” practices raise concerns over H. pylori management in children

29 Nov 2024 by

For the screening and diagnosis of paediatric Helicobacter pylori infection at a tertiary centre in Singapore, endoscopies are often skipped in favour of a “test-and-treat” approach based on noninvasive testing, a practice that deviates from recommended protocols.

Widespread “test-and-treat” practices raise concerns over H. pylori management in children

29 Nov 2024

Flu shots reduce spread of infection within households

29 Nov 2024

Influenza vaccination appears to mitigate the risk of secondary infections among unvaccinated household contacts, according to a study.

Flu shots reduce spread of infection within households

29 Nov 2024

BP control affected by COVID-19 pandemic

28 Nov 2024

The COVID-19 pandemic had a negative impact on blood pressure (BP) control, as shown in a study using ambulatory BP monitoring (ABPM).

BP control affected by COVID-19 pandemic

28 Nov 2024

High-dose VE303 reduces ARG levels in individuals with CDI

26 Nov 2024 by

Treatment with high-dose VE303, a defined bacterial consortium composed of eight strains of commensal Clostridia, was associated with a significant reduction in antibiotic resistance genes (ARGs) among individuals with Clostridioides difficile infection (CDI), according to the phase II CONSORTIUM* study presented at IDWeek 2024.

High-dose VE303 reduces ARG levels in individuals with CDI

26 Nov 2024

Nirmatrelvir/ritonavir for COVID-19 in children passes safety test

23 Nov 2024 by

Treatment of symptomatic COVID-19 with nirmatrelvir/ritonavir in children at least 6 years of age who are at risk of progression to severe disease appears to be safe and well-tolerated, with pharmacokinetic data from the open-label phase 2/3 EPIC-Peds* study indicating suitable dosing regimens for two distinct weight categories of this population.

Nirmatrelvir/ritonavir for COVID-19 in children passes safety test

23 Nov 2024

News & Updates

Filter by Specialty:

Specialty:

Nomogram identifies burned children at risk of infections

Nomogram identifies burned children at risk of infections

Why not metformin for long COVID in non-diabetics?

Why not metformin for long COVID in non-diabetics?

Wearable TENS device may zap away pain, fatigue due to long COVID

Wearable TENS device may zap away pain, fatigue due to long COVID

7 days of antibiotics as effective as 14 days for bloodstream infections

7 days of antibiotics as effective as 14 days for bloodstream infections

Meropenem-vaborbactam on par with ceftazidime-avibactam for survival in CRE infections, with an edge against resistance emergence

Meropenem-vaborbactam on par with ceftazidime-avibactam for survival in CRE infections, with an edge against resistance emergence

Widespread “test-and-treat” practices raise concerns over H. pylori management in children

Widespread “test-and-treat” practices raise concerns over H. pylori management in children

Flu shots reduce spread of infection within households

Flu shots reduce spread of infection within households

BP control affected by COVID-19 pandemic

BP control affected by COVID-19 pandemic

High-dose VE303 reduces ARG levels in individuals with CDI

High-dose VE303 reduces ARG levels in individuals with CDI

Nirmatrelvir/ritonavir for COVID-19 in children passes safety test

Nirmatrelvir/ritonavir for COVID-19 in children passes safety test